Hepatitis C Virus (HCV) and Lymphomagenesis

References

• Wotherspoon, A.C., Doglioni, C., Diss, T.C., Pan, L., Moschini, A., de Boni, M. and Isaacson, P.G. (1993) "Regression of primary low-grade B-cell gastric lymphoma of mucosa- associated lymphoid tissue type after eradication of Helicobacter pylori", Lancet 342, 575–577.
   PubMed Web of Science ®Google Scholar
• Hermine, 0., Lefrere, F., Bronowicki, J.P., Marlette, X., Jondeau, K., Eclache-Saudreau, V, Delmas, B., Valensi, F., Cacoub, P., Brechot, C., Varet, B. and Troussard, X. (2002) "Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection", New England Journal of Medicine 347, 89–94.
   Google Scholar
• Choo, Q.L., Kuo, G., Weiner, A.J., Overby, L.R., Bradley, D.W. and Houghton, M. (1989) "Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome", Science 244, 359–362.
   PubMed Web of Science ®Google Scholar
• Grakoui, A., Wychowski, C., Lin, C., Feinstone, S.M. and Rice, C.M. (1993) "Expression and identification of hepatitis C virus polyprotein cleavage products", Journal of Virology 67, 1385–1395.
   PubMed Web of Science ®Google Scholar
• Gretch, D.R. (1997) "Diagnostic tests for hepatitis C", Hepatology 26, 43S–475.
   Web of Science ®Google Scholar
• Lanford, R.E., Sureau, C., Jacob, J.R., White, R. and Fuerst, T.R. (1994) "Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR", Virology 202, 606–614.
   PubMed Web of Science ®Google Scholar
• He, X.S. and Greenberg, H.B. (2002) "CD8+ T-cell response against hepatitis C virus", Viral Immunology 15, 121–131.
   PubMed Web of Science ®Google Scholar
• Lechner, F., Wong, D.K., Dunbar, P.R., Chapman, R., Chung, R.T., Dohrenwend, P., Robbins, G., Phillips, R., Klenerman, P. and Walker, B.D. (2000) "Analysis of successful immune responses in persons infected with hepatitis C virus", Journal of Experimental Medicine 191, 1499–1512.
   PubMed Web of Science ®Google Scholar
• Wedemeyer, H., He, X.S., Nascimbeni, M., Davis, A.R., Greenberg, H.B., Hoofnagle, J.H., Liang, T.J., Alter, H. and Rehermann, B. (2002) "Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection", Journal of Immunology 169, 3447–3458.
   PubMed Web of Science ®Google Scholar
• Gruner, N.H., Gerlach, T.J., Jung, M.C., Diepolder, H.M., Schirren, C.A., Schraut, W.W., Hoffmann, R., Zachoval, R., Santantonio, T., Cucchiarini, M., Cerny, A. and Pape, G.R. (2000) "Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C", Journal of Infectious Diseases 181, 1528–1536.
   PubMed Web of Science ®Google Scholar
• Gerlach, J.T., Diepolder, H.M., Jung, M.C., Gruener, N.H., Schraut, W.W., Zachoval, R., Hoffmann, R., Schirren, C.A., Santantonio, T. and Pape, G.R. (1999) "Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C", Gastroenterology 117, 933–941.
   PubMed Web of Science ®Google Scholar
• lino, S. (2002) "Natural history of hepatitis B and C virus infections", Oncology 62\(Suppl. 1), 18–23.
   PubMed Web of Science ®Google Scholar
• Agnello, V, Chung, R.T. and Kaplan, L.M. (1992) "A role for hepatitis C virus infection in type II cryoglobulinemia", New England Journal of Medicine 327, 1490–1495.
   PubMed Web of Science ®Google Scholar
• Cacoub, P., Hausfater, P., Musset, L. and Piette, J.C. (2000) "Mixed cryoglobulinemia in hepatitis C patients", Annales de Medecine Interne (Paris) 151, 20–29.
   PubMedGoogle Scholar
• Lunel, F., Musset, L., Cacoub, P., Frangeul, L., Cresta, P., Perrin, M., Grippon, P., Hoang, C., Valla, D., Piette, J.C., Huraux, J.M. and Opolon, P. (1994) "Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage", Gastroenterology 106, 1291–1300.
   PubMed Web of Science ®Google Scholar
• Silvestri, F., Pipan, C., Barillari, G., Zaja, F., Fanin, R., Infanti, L., Russo, D., Falasca, E., Botta, G.A. and Baccarani, M. (1996) "Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders", Blood 87, 4296–4301.
   PubMed Web of Science ®Google Scholar
• Ferri, C., Caracciolo, F., Zignego, A.L., La Civita, L., Monti, M., Longombardo, G., Lombardini, F., Greco, F., Capochiani, E., Mazzoni, A., Mazzaro, C. and Pasero, G. (1994) "Hepatitis C virus infection in patients with non-Hodgkin's lymphoma", British Journal of Haematology 88, 392–394.
   PubMed Web of Science ®Google Scholar
• De Rosa, G., Gobbo, M.L., De Renzo, A., Notaro, R., Garofalo, S., Grimaldi, M., Apuzzo, A., Chiurazzi, F., Picardi, M., Matarazzo, M. and Rotoli, B. (1997) "High prevalence of hepatitis C virus infection in patients with B-cell lymphoproliferative disorders in Italy", American Journal of Hematology 55, 77–82.
   PubMed Web of Science ®Google Scholar
• Zuckerman, E., Zuckerman, T., Levine, A.M., Douer, D., Gutekunst, K., Mizokami, M., Qian, D.G., Velankar, M., Nathwani, B.N. and Fong, T.L. (1997) "Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma", Annals of Internal Medicine 127, 423–428.
   PubMed Web of Science ®Google Scholar
• Izumi, T., Sasaki, R., Miura, Y. and Okamoto, H. (1996) "B cell malignancy and hepatitis C virus infection (Letter)", Leukemia Research 20, 445.
   PubMed Web of Science ®Google Scholar
• Hanley, J., Jarvis, L., Simmonds, P., Parker, A. and Ludlam, C. (1996) "HCV and non-Hodgkin lymphoma (Letter)", Lancet 347, 1339.
   PubMed Web of Science ®Google Scholar
• Hausfater, P., Cacoub, P., Sterkers, Y., Thibault, V, Amoura, Z., Nguyen, L., Ghillani, P., Leblond, V. and Piette, J.C. (2001) "Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France", American Journal of Hematology 67, 168–171.
   PubMed Web of Science ®Google Scholar
• Thalen, D.J., Raemaekers, J., Galama, J. and Cooreman, M.P. (1997) "Absence of hepatitis C virus infection in non-Hodgkin's lymphoma", British Journal of Haematology 96, 880— 881.
   PubMed Web of Science ®Google Scholar
• Laskus, T., Radkowski, M., Wang, L.F., Vargas, H. and Rakela, J. (1997) "Lack of evidence for hepatitis G virus replication in the livers of patients coinfected with hepatitis C and G viruses", Journal of Virology 71, 7804–7806.
   PubMed Web of Science ®Google Scholar
• Boisvert, J., He, X.S., Cheung, R., Keeffe, E.B., Wright, T. and Greenberg, H.B. (2001) "Quantitative analysis of hepatitis C virus in peripheral blood and liver: replication detected only in liver", Journal of Infectious Disease 184, 827–835.
   PubMed Web of Science ®Google Scholar
• Sangar, D.V. and Carroll, A.R. (1998) "A tale of two strands: reverse-transcriptase polymerase chain reaction detection of hepatitis C virus replication", Hepatology 28, 1173–1176.
   PubMed Web of Science ®Google Scholar
• Takyar, ST., Li, D., Wang, Y, Trowbridge, R. and Gowans, E.J. (2000) "Specific detection of minus-strand hepatitis C virus RNA by reverse-transcription polymerase chain reaction on poly A(+ )-purified RNA", Hepatology 32, 382–387.
   PubMed Web of Science ®Google Scholar
• Qian, C., Camps, J., Maluenda, M.D., Civeira, M.P. and Prieto, J. (1992) "Replication of hepatitis C virus in peripheral blood mononuclear cells. Effect of alpha-interferon therapy", Journal of Hepatology 16, 380–383.
   PubMed Web of Science ®Google Scholar
• Muller, H.M., Pfaff, E., Goeser, T., Kallinowski, B., Solbach, C. and Theilmann, L. (1993) "Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication", Journal of General Virology 74, 669–676.
   PubMed Web of Science ®Google Scholar
• Schmidt, W.N., Klinzman, D., LaBrecque, D.R., Macfarlane, D.E. and Stapleton, J.T. (1995) "Direct detection of hepatitis C virus (HCV) RNA from whole blood, and comparison with HCV RNA in plasma and peripheral blood mononuclear cells", Journal of Medical Virology 47, 153–160.
   PubMed Web of Science ®Google Scholar
• Wang, J.T., Sheu, IC., Lin, IT., Wang, T.H. and Chen, D.S. (1992) "Detection of replicative form of hepatitis C virus RNA in peripheral blood mononuclear cells", Journal of Infectious Disease 166, 1167–1169.
   PubMed Web of Science ®Google Scholar
• Laskus, T., Radkowski, M., Wang, L.F., Vargas, H. and Rakela, J. (1998) "The presence of active hepatitis C virus replication in lymphoid tissue in patients coinfected with human immunodefi-ciency virus type 1", Journal of Infectious Disease 178, 1189–1192.
   PubMed Web of Science ®Google Scholar
• Laskus, T., Radkowski, M., Wang, L.F., Jang, S.J., Vargas, H. and Rakela, J. (1998) "Hepatitis C virus quasispecies in patients infected with HIV-1: correlation with extrahepatic viral replica-tion", Virology 248, 164–171.
   PubMed Web of Science ®Google Scholar
• Radkowski, M., Wang, L.F., Vargas, HE., Rakela, J. and Laskus, T. (1998) "Detection of hepatitis C virus replication in peripheral blood mononuclear cells after orthotopic liver transplantation", Transplantation 66, 664–666.
   PubMed Web of Science ®Google Scholar
• Sansonno, D., Lotesoriere, C., Cornacchiulo, V, Fanelli, M., Gatti, P., Iodice, G., Racanelli, V. and Dammacco, F. (1998) "Hepatitis C virus infection involves CD34(+) hematopoietic progenitor cells in hepatitis C virus chronic carriers", Blood 92, 3328–3337.
   PubMed Web of Science ®Google Scholar
• Moriya, K., Fujie, H., Shintani, Y, Yotsuyanagi, H., Tsutsumi, T., Ishibashi, K., Matsuura, Y, Kimura, S., Miyamura, T. and Koike, K. (1998) "The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice", Nature Medicine 4, 1065–1067.
   PubMed Web of Science ®Google Scholar
• Schmidt, C.M., McKillop, I.H., Cahill, P.A. and Sitzmann, J.V. (1997) "Increased MAPK expression and activity in primary human hepatocellular carcinoma", Biochemical and Biophysical Research Communications 236, 54–58.
   PubMed Web of Science ®Google Scholar
• Hayashi, J., Aoki, H., Kajino, K., Moriyama, M., Arakawa, Y. and Hino, 0. (2000) "Hepatitis C virus core protein activates the MAPK/ERK cascade synergistically with tumor promoter TPA, but not with epidermal growth factor or transforming growth factor alpha", Hepatology 32, 958–961.
   Google Scholar
• Ikeda, K., Saitoh, S., Arase, Y., Chayama, K., Suzuki, Y., Kobayashi, M., Tsubota, A., Nakamura, I., Murashima, N., Kumada, H. and Kawanishi, M. (1999) "Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: a long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis", Hepatology 29, 1124–1130.
   PubMed Web of Science ®Google Scholar
• Takimoto, M., Ohkoshi, S., Ichida, T., Takeda, Y, Nomoto, M., Asakura, H., Naito, A., Mori, S., Hata, K., Igarashi, K., Hara, H., Ohta, H., Soga, K., Watanabe, T. and Kamimura, T. (2002) "Interferon inhibits progression of liver fibrosis and reduces the risk of hepatocarcinogenesis in patients with chronic hepatitis C: a retrospective multicenter analysis of 652 patients", Digestive Diseases and Sciences 47, 170–176.
   PubMed Web of Science ®Google Scholar
• Franzin, F., Efremov, D.G., Pozzato, G., Tulissi, P., Batista, F. and Burrone, O.R. (1995) "Clonal B-cell expansions in peripheral blood of HCV-infected patients", British Journal of Haematology 90, 548–552.
   PubMed Web of Science ®Google Scholar
• Sansonno, D., De Vita, S., Iacobelli, A.R., Cornacchiulo, V, Boiocchi, M. and Dammacco, F. (1998) "Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia", Journal of Immunology 160, 3594–3601.
   PubMed Web of Science ®Google Scholar
• Magalini, AR., Facchetti, F., Salvi, L., Fontana, L., Puoti, M. and Scarpa, A. (1998) "Clonality of B-cells in portal lymphoid infiltrates of HCV-infected livers", Journal of Pathology 185, 86–90.
   PubMed Web of Science ®Google Scholar
• Racanelli, V, Sansonno, D., Piccoli, C., D'Amore, F.P., Tucci, F.A. and Dammacco, E (2001) "Molecular characterization of B cell clonal expansions in the liver of chronically hepatitis C virus-infected patients", Journal of Immunology 167, 21–29.
   PubMed Web of Science ®Google Scholar
• Kunkel, H.G., Agnello, V, Joslin, F.G., Winchester, R.J. and Capra, J.D. (1973) "Cross-idiotypic specificity among monoclonal IgM proteins with anti--y-globulin activity", Journal of Experimental Medicine 137, 331–342.
   PubMed Web of Science ®Google Scholar
• Sasso, E.H. (2000) "The rheumatoid factor response in the etiology of mixed cryoglobulins associated with hepatitis C virus infection", Annales de Medecine Interne (Paris) 151, 30–40.
   PubMedGoogle Scholar
• Ivanovski, M., Silvestri, E, Pozzato, G., Anand, S., Mazzaro, C., Burrone, O.R. and Efremov, D.G. (1998) "Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas", Blood 91, 2433–2442.
   PubMed Web of Science ®Google Scholar
• De Re, V, De Vita, S., Marzotto, A., Rupolo, M., Gloghini, A., Pivetta, B., Gasparotto, D., Carbone, A. and Boiocchi, M. (2000) "Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia", Blood 96, 3578–3584.
   PubMed Web of Science ®Google Scholar
• Marasca, R., Vaccari, P., Luppi, M., Zucchini, P., Castelli, I., Barozzi, P., Cuoghi, A. and Torelli, G. (2001) "Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma", American Journal of Pathology 159, 253 — 261.
   PubMed Web of Science ®Google Scholar
• Chan, C.H., Hadlock, K.G., Foung, S.K.H. and Levy, S. (2001) "VH1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen", Blood 97, 1023–1026.
   PubMed Web of Science ®Google Scholar
• Quinn, ER., Chan, C.H., Hadlock, KG., Foung, S.K.H., Flint, M. and Levy, S. (2001) "The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis", Blood 98, 3745–3749.
   PubMed Web of Science ®Google Scholar
• Clark, E.A. and Lane, P.J.L. (1991) "Regulation of human B-cell activation and adhesion", Annual Review of Immunology 9, 97–127.
   PubMed Web of Science ®Google Scholar
• De Vita, S., De Re, V, Gasparotto, D., Ballare, M., Pivetta, B., Ferraccioli, G., Pileri, S., Boiocchi, M. and Monteverde, A. (2000) "Oligoclonal non-neoplastic B cell expansion is the key feature of type II missed cryoglobulinemia: clinical and molecular finding do not support a bone marrow pathologic diagnosis of indolent B cell lymphoma", Arthritis and Rheumatism 43, 94–102.
   PubMed Web of Science ®Google Scholar
• Zignego, AL., Ferri, C., Giannelli, E, Giannini, C., Caini, P., Monti, M., Marrocchi, ME., Di Pietro, E., La Villa, G., Laffi, G. and Gentilini, P. (2002) "Prevalence of bc1-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas", Annals of Internal Medicine 137, 571–580.
   PubMed Web of Science ®Google Scholar
• Pileri, P., Uematsu, Y, Campagnoli, S., Galli, G., Falugi, F., Petracca, R., Weiner, A.J., Houghton, M., Rosa, D., Grandi, G. and Abrignani, S. (1998) "Binding of hepatitis C virus to CD81", Science 282, 938–941.
   PubMed Web of Science ®Google Scholar
• Engel, P. and Tedder, T.F. (1994) "New CD from the B cell section of the Fifth International Workshop on human leukocyte differentiation antigens", Leukocyte Lymphoma 13\(Suppl. 1), 61–64.
   PubMed Web of Science ®Google Scholar
• Flint, M., Quinn, ER. and Levy, S. (2001) "In search of hepatitis C virus receptor(s)", Clinics in Liver Disease 5, 873–893.
   PubMedGoogle Scholar
• Higginbottom, A., Quinn, ER., Kuo, C.C., Flint, M., Wilson, L.H., Bianchi, E., Nicosia, A., Monk, P.N., McKeating, J.A. and Levy, S. (2000) "Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2", Journal of Virology 74, 3642–3649.
   PubMed Web of Science ®Google Scholar
• Drummer, HE., Wilson, K.A. and Poumbourios, P. (2002) "Identification of the hepatitis C virus E2 glycoprotein binding site on the large extracellular loop of CD81", Journal of Virology 76, 11143–11147.
   PubMed Web of Science ®Google Scholar
• Flint, M., Maidens, C., Loomis-Price, L.D., Shotton, C., Dubuisson, J., Monk, P., Higginbottom, A., Levy, S. and McKeating, J.A. (1999) "Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81", Journal of Virology 73, 6235–6244.
   PubMed Web of Science ®Google Scholar
• Yagnik, AT., Lahm, A., Meola, A., Roccasecca, R.M., Ercole, B.B., Nicosia, A. and Tramontano, A. (2000) "A model for the hepatitis C virus envelope glycoprotein E2", Proteins 40, 355–366.
   PubMed Web of Science ®Google Scholar
• Owsianka, A., Clayton, R.F., Loomis-Price, L.D., McKeating, J.A. and Patel, A.H. (2001) "Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimila-rities between different forms of E2", Journal of General Virology 82, 1877–1883.
   PubMed Web of Science ®Google Scholar
• Petracca, R., Falugi, F., Galli, G., Norais, N., Rosa, D., Campagnoli, S., Burgio, V, Di Stasi°, E., Giardina, B., Houghton, M., Abrignani, S. and Grandi, G. (2000) "Structure-function analysis of hepatitis C virus envelope-CD81 binding", Journal of Virology 74,4824–4830.
   PubMed Web of Science ®Google Scholar
• Meola, A., Sbardellati, A., Bruni Ercole, B., Cerretani, M., Pezzanera, M., Ceccacci, A., Vitelli, A., Levy, S., Nicosia, A., Traboni, C., McKeating, J. and Scarselli, E. (2000) "Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection", Journal of Virology 74, 5933–5938.
   PubMed Web of Science ®Google Scholar
• Tseng, C.T.K. and Klimpel, G.R. (2002) "Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell function", Journal of Experimental Medicine 195, 43–49.
   PubMed Web of Science ®Google Scholar
• Crotta, S., Stilla, A., Wack, A., D'Andrea, A., Nuti, S., D'Oro, U., Mosca, M., Filliponi, F., Brunetto, R.M., Bonin°, F., Abrignani, S. and Valiante, N.M. (2002) "Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein", Journal of Experimental Medicine 195, 35–41.
   Google Scholar
• Bradbury, L.E., Kansas, G.S., Levy, S., Evans, R.L. and Tedder, T.F. (1992) "The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules", Journal of Immunology 149, 2841–2850.
   PubMed Web of Science ®Google Scholar
• Carter, R.H. and Fearon, D.T. (1992) "CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes", Science 256, 105–107.
   PubMed Web of Science ®Google Scholar
• Fried, M.W., Shiffman, M.L., Reddy, K.R., Smith, C., Marinos, G., Goncales, Jr., FL., Haussinger, D., Diago, M., Carosi, G., Dhumeaux, D., Craxi, A., Lin, A., Hoffman, J. and Yu, J. (2002) "Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection", New England Journal of Medicine 347, 975–982.
   PubMed Web of Science ®Google Scholar
• Mazzaro, C., Franzin, F., Tulissi, P., Pussini, E., Crovatto, M., Carniello, G.S., Efremov, D.G., Burrone, 0., Santini, G. and Pozzato, G. (1996) "Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy", Cancer 77, 2604–2613.
   PubMed Web of Science ®Google Scholar
• Ferri, C., Marzo, E., Longombardo, G., Lombardini, F., La Civita, L., Vanacore, R., Liberati, A.M., Gerli, R., Greco, F., Moretti, A., Monti, M., Gentilini, P., Bombardieri, S. and Zignego, AL. (1993) "Interferon-alpha in mixed cryoglobulinemia patients: a random-ized, crossover-controlled trail", Blood 81, 1132–1136.
   PubMed Web of Science ®Google Scholar
• Mazzaro, C., Pazzato, G., Moretti, M., Crovatto, M., Modolo, Mazzi, G. and Santini, G. (1994) "Long-term effects of alpha-interferon therapy for type II mixed cryoglobulinemia", Haemato-logica 79, 342–349.
   PubMed Web of Science ®Google Scholar
• Misiani, R., Bellavita, P., Fenili, D., Vicari, 0., Marchesi, D., Sironi, P.L., Zilio, R, Vernocchi, A., Massazza, M., Vendramin, G., Tanzi, E. and Zanetti, A. (1994) "Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus", New England Journal of Medicine 330, 751–756.
   PubMed Web of Science ®Google Scholar
• Casato, M., Mecucci, C., Agnello, V, Fiorilli, M., Knight, GB., Matteucci, C., Gao, L. and Kay, J. (2002) "Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bc1-2 overexpression, and type II cryoglobulinemia", Blood 99, 2259–2261.
   PubMed Web of Science ®Google Scholar
• Zuckerman, E., Zuckerman, T., Sahar, D., Streichman, S., Attias, D., Sabo, E., Yeshunm, D. and Rowe, J.M. (2001) "The effect of antiviral therapy on t(14;18) translocation and inrununoglobulin gene rearrangement in patients with chronic hepatitis C virus infection", Blood 97, 1555–1559.
   PubMed Web of Science ®Google Scholar
• Agnello, V, Abel, G., Elfahal, M., Knight, G.B. and Zhang, Q.X. (1999) "Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor", Proceedings in National Academy of Science USA 96, 12766–12771.
   PubMed Web of Science ®Google Scholar
• Scarselli, E., Ansuini, H., Cerino, R., Roccasecca, R.M., Acali, S., Filocamo, G., Traboni, C., Nicosia, A., Cortese, R. and Vitelli, A. (2002) "The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus", EMBO Journal 21, 5017–5025.
   PubMed Web of Science ®Google Scholar